Literature DB >> 27230619

Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".

Atsushi Tanaka1,2, Hajime Takikawa3,4, Satoshi Mochida5,6, Kazuhiko Koike7,6, Hiroto Miwa8,9, Toru Shimosegawa10,9.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27230619     DOI: 10.1007/s00535-016-1223-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  11 in total

1.  Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Gut       Date:  2015-09-14       Impact factor: 23.059

2.  Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Hepatology       Date:  2015-09-15       Impact factor: 17.425

Review 3.  Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  J Hepatol       Date:  2015-09-15       Impact factor: 25.083

4.  Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Gastroenterology       Date:  2015-09-15       Impact factor: 22.682

5.  Primary biliary cirrhosis.

Authors:  J A DAUPHINEE; J C SINCLAIR
Journal:  Can Med Assoc J       Date:  1949-07       Impact factor: 8.262

6.  Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan.

Authors: 
Journal:  Hepatol Res       Date:  2014-01       Impact factor: 4.288

Review 7.  Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.

Authors:  M E Gershwin; A A Ansari; I R Mackay; Y Nakanuma; A Nishio; M J Rowley; R L Coppel
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

Review 8.  Primary biliary cirrhosis.

Authors:  Elizabeth J Carey; Ahmad H Ali; Keith D Lindor
Journal:  Lancet       Date:  2015-09-11       Impact factor: 79.321

Review 9.  Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.

Authors:  Ghulam Abbas; Keith D Lindor
Journal:  Expert Opin Pharmacother       Date:  2010-02       Impact factor: 3.889

10.  Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

View more
  4 in total

Review 1.  Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics.

Authors:  Ji-Won Park; Jung-Hee Kim; Sung-Eun Kim; Jang Han Jung; Myoung-Kuk Jang; Sang-Hoon Park; Myung-Seok Lee; Hyoung-Su Kim; Ki Tae Suk; Dong Joon Kim
Journal:  Biomedicines       Date:  2022-05-31

Review 2.  Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.

Authors:  Satoru Joshita; Takeji Umemura; Eiji Tanaka; Masao Ota
Journal:  Clin J Gastroenterol       Date:  2017-11-20

3.  Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.

Authors:  Ping Ni; Ruoting Men; Mengyi Shen; Tingting Wang; Chen Huang; Xiaoli Fan; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-06-02

4.  Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.

Authors:  Yukihisa Fujinaga; Tadashi Namisaki; Yuki Tsuji; Junya Suzuki; Koji Murata; Soichi Takeda; Hiroaki Takaya; Takashi Inoue; Ryuichi Noguchi; Yuki Fujimoto; Masahide Enomoto; Norihisa Nishimura; Koh Kitagawa; Kosuke Kaji; Hideto Kawaratani; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.